|
Trifluridine/tipiracil (TAS-102) Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Early 1: 1
Top Sponsors
- M.D. Anderson Cancer Center1
Indications
- Dynamic Tumor Resistance1
- Metastatic Colorectal Cancer1
- Cancer1
Houston, Texas1 trial
ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer
MD Anderson Cancer Center
Early 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.